The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy

Journal of Bone and Joint Surgery - Series B

Volumn 92, Issue 8, 2010, Pages 1152-1159

  Hayek, S ^a   Gershon, A ^a,b   Wientroub, S ^a   Yizhar, Z ^a,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Developmental Physiotherapy Meshi School   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ANKLE; ARTICLE; CAST APPLICATION; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GAIT DISORDER; GASTROCNEMIUS MUSCLE; GROSS MOTOR FUNCTION MEASURE; HUMAN; MALE; MOTOR CONTROL; PASSIVE MOVEMENT; PES EQUINUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANGE OF MOTION; RATING SCALE; SCORING SYSTEM; THERAPY EFFECT; TREATMENT DURATION;

ANKLE JOINT; BOTULINUM TOXIN TYPE A; CASTS, SURGICAL; CEREBRAL PALSY; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EQUINUS DEFORMITY; FEMALE; GAIT; HUMANS; MALE; MUSCLE TONUS; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 77955363230     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B8.23086     Document Type: Article

References (30)

1. Houltram J, Noble I, Boyd RN, et al. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation. Eur J Neurol 2001;8(Suppl5):194-202.
2. Boyd RN, Pliatsios V, Starr R, Wolfe R, Graham HK. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 2000;42:32-41.
3. Metaxiotis D, Siebel A, Doederlein L. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop 2002;394:177-85.
4. Flett PJ, Stern LM, Waddy H, et al. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 1999;35:71-9.
5. Graham HK, Aoki KR, Autti-Rämö I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67-79.
6. Boyd RN, Graham JEA, Nattrass GR, Graham HK. Medium-term response characterization and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. Eur J Neurol 1999;6(Suppl4):37-45.
7. Ackman JD, Russman BS, Thomas SS, et al. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 2005;47:620-7.
8. Corry IS, Cosgrove AP, Duffy CM, et al. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 1998;18:304-11.
9. Kay RM, Rethlefsen SA, Fern-Buneo A, Wren TA, Skaggs TA. Botulinum toxin as an adjunct to serial casting treatments in children with cerebral palsy. J Bone Joint Surg [Am] 2004;86-A:2377-84.
10. Glanzman AM, Kim H, Swaminathan K, Beck T. Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: a retrospective analysis. Dev Med Child Neurol 2004;46:807-11.
11. Boyd RN, Hays RM. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol 2001;8(Suppl5):1-20.
12. Drouin LM, Malouin F, Richards CL, Marcoux S. Correlation between the gross motor function measure scores and gait spatiotemporal measures in children with neurological impairments. Dev Med Child Neurol 1996;38:1007-19.
13. Russell DJ, Rosenbaum PL, Avery LM, Lane M. Gross motor function measure: (GMFM-66 & GMFM-88) user's manual. London: Mac Keith Press, 2002:25-41.
14. Löwing K, Carlberg EB. Reliability of the selective motor control scale in children with cerebral palsy. Adv Physiother 2009;11:58-63.
15. Boyd RN, Kerr Graham H. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 2007;6:(Suppl):523-35.
16. Mackey AH, Lobb GL, Walt SE, Stott NS. Reliability and validity of the Observational Gait Scale in children with spastic diplegia. Dev Med Child Neurol 2003;45:4-11.
17. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7.
18. Fosang AL, Galea MP, McCoy AT, Reddihough DS, Story I. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Dev Med Child Neurol 2003;45:664-70.
19. Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil 2005;27:7-18.
20. Desloovere L, Molenaers G, Jonkers I, et al. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. Eur J Neurol 2001;8(Suppl5):75-87.
21. Molenaers G, Desloovere K, Eyssen M, et al. Botulinum toxin type A treatment of cerebral palsy: an integrated approach. Eur J Neurol 1999;6(Suppl4):51-7.
22. Reddihough DS, King JA, Coleman GJ, et al. Funtional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Dev Med Child Neurol 2002;44:820-7.
23. Bottos M, Benedetti MG, Salucci P, Gasparroni V, Gianni S. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol 2003;45:758-62.
24. Sutherland D, Kaufman K, Wyatt M, Chambers H. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis study. Gait Posture 1996;4:269-79.
25. Koman LA, Mooney JF 3rd, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. Pediatr Orthop 2000;20:108-15.
26. Koman LA, Brashear A, Rosenfeld S, et al. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 2001;108:1062-71.
27. Fattal-Valevski A, Giladi N, Domanievitz D, et al. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy. J Child Neurol 2002;17:272-7.
28. Cardoso ES, Rodrigues BM, Barroso M, et al. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy. Pediatr Neurol 2006;34:106-9.
29. Gracies JM. Physiological effects of botulinum toxin in spasticity. Mov Disord 2004;19(Suppl8):120-8.
30. Scholtes VA, Dallmeijer AJ, Knol DL, et al. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy. Pediatr Neurol 2007;36:30-9.